ClinicalTrials.gg
Sign In

Biological

HUCART19 clinical trials

Also written huCART19.

studies test it
5
open now
3
in phase 3
0
first study started
2014

Keep track of what changes. Save the HUCART19 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Development codes

huCART19
4
huCTL019
1

Studies by the year they started

4 studies that test it; most in 2014 (1); 1 more planned to start later

Studies that test HUCART19, by start year
YearStudies
20141
20191
20231
20241

By phase

A phase 1/2 study counts in both.

Phase 1
4
Phase 2
2

What it is tested for

Each study’s main condition, where its own words name it.

Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Non-Hodgkin
1
Renal Insufficiency
1

Who runs them

Industry 0 · Other 5

University of Pennsylvania (3) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Stephan Grupp MD PhD (1)

Often tested with

Tested in the same studies.

Cyclophosphamide (1) · Autologous Anti-BCMA-CAR-TCRz/4-1BB-expressing T-lymphocytes CART-BCMA (1) · Autologous Anti-CD22 CAR-4-1BB-TCRz-transduced T-lymphocytes CART22-65s (1)

Studies

Open first, then newest update. How each study uses HUCART19 is read from its arms, and is right about nine times in ten.

Testing it · 5